Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy.
López-Rodríguez R, Hernández-Bartolomé Á, Borque MJ, Rodríguez-Muñoz Y, Martín-Vílchez S, Trapero-Marugán M, García-Buey L, Muñoz de Rueda P, Rodrigo L, Vidal-Castiñeira JR, Salmerón J, Moreno-Otero R, Sanz-Cameno P. López-Rodríguez R, et al. Genes Immun. 2013 Jul-Aug;14(5):317-24. doi: 10.1038/gene.2013.24. Epub 2013 Apr 25. Genes Immun. 2013. PMID: 23615070
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, McConkey GA, Zechner M, Klaric L, Griffiths F, Oosthuyzen W, Kousathanas A, Richmond A, Millar J, Russell CD, Malinauskas T, Thwaites R, Morrice K, Keating S, Maslove D, Nichol A, Semple MG, Knight J, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw PJM, Begg C, Walsh T, Tenesa A, Flores C, Riancho JA, Rojas-Martinez A, Lapunzina P; GenOMICC Investigators; SCOURGE Consortium; ISARICC Investigators; 23andMe COVID-19 Team; Yang J, Ponting CP, Wilson JF, Vitart V, Abedalthagafi M, Luchessi AD, Parra EJ, Cruz R, Carracedo A, Fawkes A, Murphy L, Rowan K, Pereira AC, Law A, Fairfax B, Hendry SC, Baillie JK. Pairo-Castineira E, et al. Nature. 2023 May;617(7962):764-768. doi: 10.1038/s41586-023-06034-3. Epub 2023 May 17. Nature. 2023. PMID: 37198478 Free PMC article.
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, McConkey GA, Zechner M, Klaric L, Griffiths F, Oosthuyzen W, Kousathanas A, Richmond A, Millar J, Russell CD, Malinauskas T, Thwaites R, Morrice K, Keating S, Maslove D, Nichol A, Semple MG, Knight J, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw PJM, Begg C, Walsh T, Tenesa A, Flores C, Riancho JA, Rojas-Martinez A, Lapunzina P; GenOMICC Investigators; SCOURGE Consortium; ISARICC Investigators; 23andMe COVID-19 Team; Yang J, Ponting CP, Wilson JF, Vitart V, Abedalthagafi M, Luchessi AD, Parra EJ, Cruz R, Carracedo A, Fawkes A, Murphy L, Rowan K, Pereira AC, Law A, Fairfax B, Hendry SC, Baillie JK. Pairo-Castineira E, et al. Nature. 2023 Jul;619(7971):E61. doi: 10.1038/s41586-023-06383-z. Nature. 2023. PMID: 37433877 Free PMC article. No abstract available.
Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C.
Rodríguez-Muñoz Y, Martín-Vílchez S, López-Rodríguez R, Hernández-Bartolomé A, Trapero-Marugán M, Borque MJ, Moreno-Otero R, Sanz-Cameno P. Rodríguez-Muñoz Y, et al. Aliment Pharmacol Ther. 2011 Oct;34(8):960-71. doi: 10.1111/j.1365-2036.2011.04807.x. Epub 2011 Aug 17. Aliment Pharmacol Ther. 2011. PMID: 21848603
Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.
Lopez-Rodriguez R, Trapero-Marugan M, Borque MJ, Roman M, Hernandez-Bartolome A, Rodriguez-Muñoz Y, Martin-Vilchez S, Abad-Santos F, Muñoz de Rueda P, Vidal-Castiñeira JR, Rodrigo L, Salmeron J, Moreno-Otero R, Sanz-Cameno P. Lopez-Rodriguez R, et al. Clin Pharmacol Ther. 2011 Nov;90(5):712-21. doi: 10.1038/clpt.2011.189. Epub 2011 Oct 12. Clin Pharmacol Ther. 2011. PMID: 21993426
A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.
Vidal-Castiñeira JR, López-Vázquez A, Alonso-Arias R, Moro-García MA, Martinez-Camblor P, Melón S, Prieto J, López-Rodriguez R, Sanz-Cameno P, Rodrigo L, Pérez-López R, Pérez-Álvarez R, López-Larrea C. Vidal-Castiñeira JR, et al. J Hepatol. 2012 Jun;56(6):1230-8. doi: 10.1016/j.jhep.2012.01.011. Epub 2012 Feb 7. J Hepatol. 2012. PMID: 22322230
[Effects of hepatitis B virus X protein on chronic hepatitis B pathophysiology].
Martín-Vílchez S, Moreno-Otero R, Sanz-Cameno P; Grupo CIBERehd de Hepatología del Hospital Universitario de La Princesa. Martín-Vílchez S, et al. Med Clin (Barc). 2013 Jun 4;140(11):508-13. doi: 10.1016/j.medcli.2012.09.012. Epub 2012 Dec 12. Med Clin (Barc). 2013. PMID: 23245531 Review. Spanish.
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.
Vidal-Castiñeira JR, López-Vázquez A, Martínez-Borra J, Martínez-Camblor P, Prieto J, López-Rodríguez R, Sanz-Cameno P, de la Vega J, Rodrigo L, Pérez-López R, Pérez-Álvarez R, López-Larrea C. Vidal-Castiñeira JR, et al. PLoS One. 2014 Jun 13;9(6):e99426. doi: 10.1371/journal.pone.0099426. eCollection 2014. PLoS One. 2014. PMID: 24927414 Free PMC article.
140 results